De-Escalating Treatment of Low-Risk Breast Ductal Carcinoma In Situ-Reference-Cited by-同舟云学术

De-Escalating Treatment of Low-Risk Breast Ductal Carcinoma In Situ

Published:2020-04-20 Issue:12 Volume:38 Page:1252-1254
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Lazzeroni Matteo¹,DeCensi Andrea¹²³

Affiliation:

1. Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology, IRCCS, Milan, Italy

2. Division of Medical Oncology, Ente Ospedaliero Ospedali Galliera, Genoa, Italy

3. Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.00124

Reference26 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence

3. Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ

4. Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ

5. Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora’s box

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ;European Journal of Cancer;2024-05

2. Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 Study;Journal of Clinical Oncology;2023-06-10

3. De-Escalating the Management of In Situ and Invasive Breast Cancer;Cancers;2022-09-20

4. Atypical Ductal Hyperplasia-Ductal Carcinoma In Situ Spectrum: Diagnostic Considerations and Treatment Impact in the Era of Deescalation;Surgical Pathology Clinics;2022-03

5. A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast;Cancers;2022-01-12